Teladoc stock: buy or sell
Updated on:
Apr 22nd, 2021
1
Teladoc stock brief
- Teladoc closed on Wednesday at $182.83 after inching a 1.06% and broke a streak of 3 sessions in red.
- Last February price started slicing and printed 2 consecutive lower tops. this downtrend marked a -40.64% loss(from its highs at $308.00).
- Needham & Company LLC published a strong buy rating for Teladoc on Wednesday, forecasting $235.00
- Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally.
Should I buy Teladoc stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $TDOC stock a buy?
Currently, Teladoc stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for $TDOC in the next few days, or that it may not climb higher. Simply, it doesn't match our recommended trading systems
Should I sell Teladoc stock?
Knowing when to sell a stock is even harder than knowing when to buy it. Trading strategies let us to avoid rash decisions based on our personal feelings or the buzz surrounding the market. When selling, as well as buying, our setups are very simple to follow and are only applicable for selling stocks you already own, not for selling short Teladoc stock
As a golden rule, you should never mantain an operation that produces higher than expected losses at the time of purchase. The moment to sell your stock should always be ruled by the stop-loss (automatic or manual)
Is it time to sell Teladoc stock?
In the current situation of Teladoc there is not any eligible sell setup, so Teladoc stock holders with operations in green can keep their positions
Teladoc ratings
In the last month, 3 ratings were published for Teladoc. General sentiment is bullish, with 3 out of 3 publishing optimistic forecasts
| Brokerage firm | Rating |
|---|---|
| Mar 23rd, 2021 | |
| Deutsche Bank Aktiengesellschaft | |
| Apr 15th, 2021 | |
| Needham & Company LLC | |
| Apr 21st, 2021 | |
| Needham & Company LLC | |
Teladoc stock analysis
Teladoc accumulates a selloff of -40.64% since its latest high last February at $308.00. The stock plotted 3 consecutive lower tops.
SMAs overview
Supports and resistances
The current resistance levels are:
The current supports are:
Bollinger bands
Relative strength index
The RSI broke out the oversold level of 30 in early March after just being in the oversold zone for a single day (what can be considered a strength sign). The RSI value on Wednesday was 43.47
Teladoc stock price history
Teladoc went public on Jul 1st, 2015 priced at $29.90 per share1. Since then, TDOC stock has risen by 511.47%, with an average of 102.29% per year. An investment of thousand dollars on the IPO would be valued $6,114.72 nowadays.
1: Adjusted price after possible price splits or reverse-splits
Price target for Teladoc stock
How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations post their analysis predicting how a particular stock will performance in the future.
The following table shows the price forecasts released by brokerage institutions in the last month. Again, these predictions are not direct recommendations for small investors and should not be followed blindly.
There are 3 price predictions published for Teladoc that average $232.00. Teladoc closed at $182.83 on Wednesday, so the target price is forecasting a growth by 26.89%.
| Brokerage firm | Price target |
|---|---|
| Mar 23rd, 2021 | |
| Deutsche Bank Aktiengesellschaft | $263.00 → $226.00 |
| Apr 15th, 2021 | |
| Needham & Company LLC | $235.00 |
| Apr 21st, 2021 | |
| Needham & Company LLC | $235.00 |
Earnings and financials
Teladoc Health, Inc. ($TDOC) released quarterly earnings of $-0.27 per share last February, missing the Market consensus estimate of $-0.24 per share. This quarterly report represents an earnings surprise of -12.50%. On the contrary, reported sales were $383.3 million, in line with analysts' estimates.
Compared to the same quarter one year ago, EPS was $-0.26, so reported EPS means a reduction of -3.85%. Looking at revenue, figures skyrocketed a 144.95% compared to $1.6B same quarter a year ago.Teladoc ($TDOC) is releasing quarterly financial report next Wednesday. Market estimates of $-0.62, compared to previous quarter that made $-0.27.
Teladoc performance
| Company | 1m | 3m | 6m |
|---|---|---|---|
| Teladoc ($TDOC) | -7.30% | -25.60% | -18.30% |
Important:
The comments expressed in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this paper does not know the specific scenarios of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are posted for informational purposes onlyTeladoc summary
| Wednesday, April 21st, 2021 | |
|---|---|
| Open | $179.8 |
| Close | $182.83 |
| Day range | $177.11 - $183.53 |
| Previous close | $180.91 |
| Session gain | 1.06% |
| Average true range | $8.62 |
| 50d mov avg | $210.75 |
| 100d mov avg | $217.18 |
| 200d mov avg | $213.49 |
| Earnings date | April 28th, 2021 |
Frequently asked questions
What is Teladoc stock symbol?
Is Teladoc stock a buy or sell?
Will TDOC go up?
Latest Teladoc news
- InvestorPlaceInvestors Find the Right Rx With Teladoc StockNov 19, 2020